Navigation Links
Alex's Lemonade Stand Foundation Announces Launch of Country's First Bioinformatics Lab Using 'Big Data' to Cure Childhood Cancer
Date:6/27/2016

PHILADELPHIA, June 27, 2016 /PRNewswire-USNewswire/ -- Alex's Lemonade Stand Foundation (ALSF), a leading national childhood cancer charity, announced that that it will open a state-of-the-art bioinformatics lab, using 'big data' to advance the pace of childhood cancer research. This announcement comes as Liz Scott, co-executive director of ALSF and Alex's mom, attends the National Cancer Moonshot Summit in Washington, D.C., hosted by Vice President and Dr. Biden as a participant and advocate of pediatric cancer research and awareness.

The bioinformatics lab will utilize data scientists, computer scientists, bio-informaticians, computational biologists and other scientists to analyze and decipher the huge amount of childhood cancer data being generated in research facilities across the country. The first informatics lab of its kind, discoveries will be shared to inform more research, find targets and develop new cures. By leveraging data, it will be a resource for ALSF funded researchers to provide first rate analysis of their data to further enhance their ability to accelerate cures. 

"We are excited to be able to harness the power of big data and open the ALSF Data Lab," said Jay Scott, co-executive director and Alex's dad. "Currently, the childhood cancer research community does not have a non-affiliated center to objectively analyze existing science and look for patterns to share with scientists. This is a true privilege to be able to offer this resource to the community and ultimately advance the pace of finding cures. We anticipate this new model of improving research to be up and running in the next 12 to 18 months."

In addition to announcing the establishment of the bioinformatics lab, ALSF also revealed its commitment to doubling its investment for childhood cancer research projects and family services to $150 million in the next 5 years. Kids and their families, businesses and other supporters do a simple action - hold a lemonade stand - to support the cause, among other ways.

In combination, these two initiatives will address three of the primary goals of the Moonshot Initiative and will make significant progress in providing better treatments for children with cancer. The goal of the Cancer Moonshot is to accelerate the rate of progress in cancer prevention, diagnosis, treatment and care over the next five years and to ultimately end cancer as we know it. Vice President Joe Biden called for the Summit, happening June 29 at Howard University, to bring communities together to discuss how cancer affects them and collaborate on ways to push forward. Researchers, doctors, scientists, philanthropists, advocates, patients and survivors are invited to attend the event. Liz Scott will be participating in discussions on clinical trials, treatments, philanthropy and advocacy.

About Childhood Cancer
Childhood cancer is a general term used to describe cancer in children occurring regularly, randomly and sparing no ethnic group, socioeconomic class, or geographic region. Childhood cancer extends to over a dozen types of cancers and a countless amount of subtypes. Just a few of these cancer types include: Ewing's sarcoma, glioma, leukemia, lymphoma, medulloblastoma, neuroblastoma, osteosarcoma, retinoblastoma, rhabdomyosarcoma and Wilms' tumor.  In the United States, childhood cancer is the leading cause of death by disease in children under the age of 15. Every day, approximately 250 kids around the world die from cancer, accounting for 91,250 losing their lives to the disease every year.

About Alex's Lemonade Stand Foundation
Alex's Lemonade Stand Foundation (ALSF) emerged from the front yard lemonade stand of cancer patient Alexandra "Alex" Scott (1996-2004). In 2000, 4-year-old Alex announced that she wanted to hold a lemonade stand to raise money to help find a cure for all children with cancer. Since Alex held that first stand, the Foundation bearing her name has evolved into a national fundraising movement, complete with thousands of supporters across the country carrying on her legacy of hope. To date, Alex's Lemonade Stand Foundation, a registered 501(c)3 charity, has raised more than $120 million toward fulfilling Alex's dream of finding a cure, funding over 550 pediatric cancer research projects nationally. For more information on Alex's Lemonade Stand Foundation, visit AlexsLemonade.org.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alexs-lemonade-stand-foundation-announces-launch-of-countrys-first-bioinformatics-lab-using-big-data-to-cure-childhood-cancer-300290567.html


'/>"/>
SOURCE Alex's Lemonade Stand Foundation
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Immigrant Journey Awards Presented to Outstanding North Texas Immigrants
2. Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard
3. LGC Maine Standards Announces Release of VALIDATE® D-Dimer Calibration Verification / Linearity Test Kit
4. Amendia Inc. Launches Its Ceres™- C Stand-alone Cervical Interbody
5. LGC Maine Standards Announces Release of VALIDATE® Fertility 1 and Fertility 2 Calibration Verification/Linearity Test Kits
6. Dr. Gary B. Fogel to Receive AIAA San Diego Outstanding Achievement Award
7. Shimadzu’s New Inductively Coupled Plasma Mass Spectrometer (ICP-MS) Offers Outstanding Reliability, Exceptional Ease of Use, and the Industry’s Lowest Operating Costs
8. ACRES Endorses MAGI’s Standard CTA Template
9. Prism Awards for Photonics Innovation honor nine companies for outstanding new products
10. Benchmark Research announces the promotion of two long-standing Principal Investigators.
11. ECRI Institute Puts Antibiotic Bone Cement for Joint Replacement on the Stand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):